Feasibility of a Cognitive-Behavioral and Environmental Intervention for Sleep-Wake Difficulties in Community-Dwelling Cancer Patients Receiving Palliative Care

Cancer Nursing
Marie Solange BernatchezMichèle Aubin

Abstract

High rates of sleep-wake difficulties have been found in patients with cancer receiving palliative care. Pharmacotherapy is the most frequently used treatment option to manage these difficulties despite numerous adverse effects and the absence of empirical evidence of its efficacy and innocuity in palliative care. This pilot study aimed to assess the feasibility and acceptability of a cognitive-behavioral and environmental intervention (CBT-E) to improve insomnia and hypersomnolence in patients with a poor functioning level and to collect preliminary data on its effects. Six patients with cancer receiving palliative care (Eastern Cooperative Oncology Group score 2-3), who had insomnia and/or hypersomnolence, received 1 CBT-E individual session at home. They applied the strategies for 3 weeks. Patients completed the Insomnia Severity Index, the Epworth Sleepiness Scale, a daily sleep diary, and a 24-hour actigraphic recording (7 days) at pretreatment and posttreatment, in addition to a semistructured interview (posttreatment). Participants found strategies easy to apply most of the time, and none was rated as impossible to use because of their health condition. However, their adherence and satisfaction toward CBT-E were highly v...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Dec 1, 1982·American Journal of Clinical Oncology·M M OkenP P Carbone
Sep 18, 2004·Psycho-oncology·Marie-Hélène SavardHans Ivers
May 10, 2005·Journal of the American Geriatrics Society·Cathy A AlessiKaren R Josephson
Feb 3, 2006·The American Journal of Hospice & Palliative Care·Amit SoodCharles L Loprinzi
Apr 6, 2006·Palliative & Supportive Care·Daniele StagnoWilliam Breitbart
Apr 25, 2006·Journal of Palliative Medicine·Elizabeth A Kvale, John L Shuster
Nov 7, 2006·Psycho-oncology·Tatsuo AkechiYosuke Uchitomi
May 25, 2007·Sleep·Timothy MorgenthalerUNKNOWN American Academy of Sleep Medicine
Apr 17, 2008·International Journal of Palliative Nursing·Brenda Hearson, Jo-Ann V Sawatzky
Sep 12, 2009·The American Journal of Hospice & Palliative Care·Wael LasheenDilara Seyidova Khoshknabi
May 20, 2011·Journal of Circadian Rhythms·James F GrutschWilliam Jm Hrushesky
Sep 12, 2012·The American Journal of Hospice & Palliative Care·Dominique DuclouxSophie Pautex
May 2, 2014·Journal of Pain and Symptom Management·Aleksandra Kotlinska-LemieszekPål Klepstad
Jun 14, 2014·Chronobiology International·Francis LéviUNKNOWN ARTBC Chronotherapy Group
Jul 2, 2014·Chronobiology International·Wen-Pei Chang, Chia-Chin Lin
Aug 28, 2015·Journal of Pain and Symptom Management·Sebastiano MercadanteGiampiero Porzio
May 3, 2016·Annals of Internal Medicine·Amir QaseemUNKNOWN Clinical Guidelines Committee of the American College of Physicians

❮ Previous
Next ❯

Citations

Jan 25, 2021·Sleep Medicine Clinics·Sommer AgnewMegan R Crawford

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.